Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor β

European Cytokine Network

Volumn 7, Issue 1, 1996, Pages 59-66

  Zissel, Gemot ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

1L 4; Alveolar macrophages; Cytokine release; IL 10; TGF

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; PROTEIN SECRETION;

BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES, ALVEOLAR; SECRETORY RATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030005134     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Roth M D, Golub S H. 1993. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta 1 to suppress lymphocyte activation. J. Leukoc Biol. 53:366.